News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
King Pharmaceuticals®, Inc., Acura Pharmaceuticals, Inc. Pain Drug Gets Priority Review
March 3, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
March 3 (Reuters) - Acura Pharmaceuticals Inc and King Pharmaceuticals Inc said U.S. health regulators granted a priority review for their experimental pain drug Acurox.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
Business
Navigating Funding Freezes and AI Frontiers
June 20, 2025
·
1 min read
·
Lori Ellis
Vaccines
Quick on Its Feet: Novavax Adapts to Continued Regulatory Uncertainty
June 20, 2025
·
3 min read
·
Heather McKenzie
Regulatory
Makary Doubles Down on Push To ‘Modernize’ FDA, Eyes Speedier Reviews
June 18, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Senate Republicans Drop Orphan Drug Exemptions From ‘One Big Beautiful Bill’
June 18, 2025
·
2 min read
·
Tristan Manalac